Skip to content
Menu

JP Morgan Maintains Overweight on Imax, Raises Price Target to $58

Benzinga Newsdesk 1 month ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

JP Morgan analyst David Karnovsky maintains Imax (NYSE:IMAX) with a Overweight and raises the price target from $50 to $58.

JP Morgan analyst David Karnovsky maintains Imax (NYSE:IMAX) with a Overweight and raises the price target from $50 to $58.

Read at benzinga.com

← All stock news